日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Therapeutic synergies that overcome carboplatin resistance in triple-negative breast cancer

克服三阴性乳腺癌卡铂耐药性的治疗协同作用

Altman, Julia E; Valentine, Aaron; Dashti-Gibson, Nina; Zboril, Emily K; Boyd, David C; Myrick, Rachel K; Olex, Amy L; Dozmorov, Mikhail G; Harrell, J Chuck

Beyond blacklists: a critical assessment of exclusion set generation strategies and alternative approaches

超越黑名单:对排除集生成策略和替代方法的批判性评估

Wall, Brydon P G; Ogata, Jonathan D; Nguyen, My; Olex, Amy L; Floros, Konstantinos V; Faber, Anthony C; McClay, Joseph L; Harrell, J Chuck; Dozmorov, Mikhail G

scHiCcompare: An R Package for Differential Analysis of Single-cell Hi-C Data

scHiCcompare:用于单细胞Hi-C数据差异分析的R软件包

Nguyen, My; Wall, Brydon P G; Harrell, J Chuck; Dozmorov, Mikhail G

Advancing Antibody-Drug Conjugates: Precision Oncology Approaches for Breast and Pancreatic Cancers

推进抗体药物偶联物:乳腺癌和胰腺癌的精准肿瘤治疗方法

Yajaman, Dhanvin R; Oh, Youngman; Trevino, Jose G; Harrell, J Chuck

Beyond Blacklists: A Critical Assessment of Exclusion Set Generation Strategies and Alternative Approaches

超越黑名单:对排除集生成策略和替代方法的批判性评估

Wall, Brydon P G; Ogata, Jonathan D; Nguyen, My; Olex, Amy L; Floros, Konstantinos V; Faber, Anthony C; McClay, Joseph L; Harrell, J Chuck; Dozmorov, Mikhail G

Machine and Deep Learning Methods for Predicting 3D Genome Organization

用于预测三维基因组结构的机器学习和深度学习方法

Wall, Brydon P G; Nguyen, My; Harrell, J Chuck; Dozmorov, Mikhail G

A triple hormone receptor ER, AR, and VDR signature is a robust prognosis predictor in breast cancer

雌激素受体 (ER)、雄激素受体 (AR) 和维生素D受体 (VDR) 三重激素受体特征是乳腺癌预后的一个可靠预测因子。

Omar, Mohamed; Harrell, J Chuck; Tamimi, Rulla; Marchionni, Luigi; Erdogan, Cihat; Nakshatri, Harikrishna; Ince, Tan A

The Transformative Role of 3D Culture Models in Triple-Negative Breast Cancer Research

3D培养模型在三阴性乳腺癌研究中的变革性作用

Bittman-Soto, Xavier S; Thomas, Evelyn S; Ganshert, Madeline E; Mendez-Santacruz, Laura L; Harrell, J Chuck

Author Correction: Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft

作者更正:在三阴性乳腺癌患者来源的异种移植模型中获得卡铂耐药性期间,3D基因组发生重连。

Dozmorov, Mikhail G; Marshall, Maggie A; Rashid, Narmeen S; Grible, Jacqueline M; Valentine, Aaron; Olex, Amy L; Murthy, Kavita; Chakraborty, Abhijit; Reyna, Joaquin; Figueroa, Daniela Salgado; Hinojosa-Gonzalez, Laura; Da-Inn Lee, Erika; Baur, Brittany A; Roy, Sushmita; Ay, Ferhat; Harrell, J Chuck

The Human Intermediate Prolactin Receptor I-tail Contributes Breast Oncogenesis by Targeting Ras/MAPK Pathway.

人类中间催乳素受体 I 尾通过靶向 Ras/MAPK 通路促进乳腺癌发生

Shen Shanwei, Radhakrishnan Senthil K, Harrell J Chuck, Puchalapalli Madhavi, Koblinski Jennifer, Clevenger Charles